Silence Therapeutics plc

Ownership Transactions Reported by 8 Insiders

Symbol
SLN on Nasdaq, SLNCF on OTC
Location
72 Hammersmith Road, London, United Kingdom

There are no Buy or Sell transactions made by insiders since 1/9/2024

Silence Therapeutics plc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Steven J. Romano EVP and Chief R&D Officer Jan 2, 2025
David Lemus Director Jan 2, 2025
Rhonda Hellums Chief Financial Officer Jan 2, 2025
Michael H. Davidson Director Jan 2, 2025
James Ede-Golightly Director Jan 2, 2025
Iain Ross Director Jan 2, 2025
Craig A. Tooman President and CEO, Director Jan 2, 2025
Griffiths Richard Ian 10%+ Owner Jan 2, 2025

Recent Insider Transactions by Companies or Individuals for Silence Therapeutics plc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.